Literature DB >> 33554856

SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.

Palur V Raghuvamsi1,2, Nikhil K Tulsian1,3, Firdaus Samsudin2, Xinlei Qian4, Kiren Purushotorman4, Gu Yue4, Mary M Kozma4, Wong Y Hwa5, Julien Lescar5, Peter J Bond1,2, Paul A MacAry4, Ganesh S Anand1,6.   

Abstract

The spike (S) protein is the main handle for SARS-CoV-2 to enter host cells via surface angiotensin-converting enzyme 2 (ACE2) receptors. How ACE2 binding activates proteolysis of S protein is unknown. Here, using amide hydrogen-deuterium exchange mass spectrometry and molecular dynamics simulations, we have mapped the S:ACE2 interaction interface and uncovered long-range allosteric propagation of ACE2 binding to sites necessary for host-mediated proteolysis of S protein, critical for viral host entry. Unexpectedly, ACE2 binding enhances dynamics at a distal S1/S2 cleavage site and flanking protease docking site ~27 Å away while dampening dynamics of the stalk hinge (central helix and heptad repeat [HR]) regions ~130 Å away. This highlights that the stalk and proteolysis sites of the S protein are dynamic hotspots in the prefusion state. Our findings provide a dynamics map of the S:ACE2 interface in solution and also offer mechanistic insights into how ACE2 binding is allosterically coupled to distal proteolytic processing sites and viral-host membrane fusion. Thus, protease docking sites flanking the S1/S2 cleavage site represent alternate allosteric hotspot targets for potential therapeutic development.
© 2021, Raghuvamsi et al.

Entities:  

Keywords:  ACE2; HDXMS; SARS-CoV-2; allostery; biochemistry; chemical biology; molecular biophysics; spike; structural biology; virus-host interactions

Year:  2021        PMID: 33554856     DOI: 10.7554/eLife.63646

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  29 in total

Review 1.  Advances in Hydrogen/Deuterium Exchange Mass Spectrometry and the Pursuit of Challenging Biological Systems.

Authors:  Ellie I James; Taylor A Murphree; Clint Vorauer; John R Engen; Miklos Guttman
Journal:  Chem Rev       Date:  2021-09-07       Impact factor: 72.087

Review 2.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Limei Cheng; Jaclyn Frishcosy; Yuta Huzumi; Yuchi Qiu; Tom Schluckbier; Xiaoqi Wei; Guo-Wei Wei
Journal:  Chem Rev       Date:  2022-05-20       Impact factor: 72.087

3.  Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.

Authors:  Tomokazu Ohishi; Takayuki Hishiki; Mirza S Baig; Sajjan Rajpoot; Uzma Saqib; Tomohiko Takasaki; Yukihiko Hara
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

4.  microRNA, the Innate-Immune System and SARS-CoV-2.

Authors:  James M Hill; Walter J Lukiw
Journal:  Front Cell Infect Microbiol       Date:  2022-06-16       Impact factor: 6.073

5.  Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.

Authors:  Jaspreet Jain; Delia Susan-Resiga; Ursula Andréo; Rachid Essalmani; Alexandra Evagelidis; Rabeb Mouna Derbali; David N Huynh; Frédéric Dallaire; Mélanie Laporte; Adrien Delpal; Priscila Sutto-Ortiz; Bruno Coutard; Claudine Mapa; Keith Wilcoxen; Etienne Decroly; Tram Nq Pham; Éric A Cohen; Nabil G Seidah
Journal:  J Virol       Date:  2022-03-28       Impact factor: 6.549

6.  Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.

Authors:  Tyler N Starr; Allison J Greaney; Adam S Dingens; Jesse D Bloom
Journal:  Cell Rep Med       Date:  2021-04-05

7.  Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.

Authors:  Tyler N Starr; Allison J Greaney; Adam S Dingens; Jesse D Bloom
Journal:  bioRxiv       Date:  2021-02-22

8.  Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction.

Authors:  Shijulal Nelson-Sathi; P K Umasankar; E Sreekumar; R Radhakrishnan Nair; Iype Joseph; Sai Ravi Chandra Nori; Jamiema Sara Philip; Roshny Prasad; K V Navyasree; Shikha Ramesh; Heera Pillai; Sanu Ghosh; T R Santosh Kumar; M Radhakrishna Pillai
Journal:  BMC Mol Cell Biol       Date:  2022-01-07

9.  The Immunopathobiology of SARS-CoV-2 Infection.

Authors:  Milankumar Patel; Farah Shahjin; Jacob D Cohen; Mahmudul Hasan; Jatin Machhi; Heerak Chugh; Snigdha Singh; Srijanee Das; Tanmay A Kulkarni; Jonathan Herskovitz; Douglas D Meigs; Ramesh Chandra; Kenneth S Hettie; R Lee Mosley; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

Review 10.  How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?

Authors:  Nabil G Seidah; Antonella Pasquato; Ursula Andréo
Journal:  Viruses       Date:  2021-06-25       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.